c-Kit
-
Upload
barry-weaver -
Category
Documents
-
view
39 -
download
0
description
Transcript of c-Kit
c-Kit A proto-oncogene Encodes a receptor tyrosine kinase type III (similar to PDGFR) Family characteristics:
5 immunoglobulin-like (Ig) domains Cytoplasmic tyrosine kinase domain with large kinase insert
Mol, C.D et al. Journal of Biological Chemistry. 2004, 279 (30). 31655-31663
Stem Cell Factor (SCF)
Important in: Hematopoietic cell survival, proliferation and differentiation Mast cell production and function Melanocyte, germ cell and intestinal pacemaker cell development
Predominant form is bivalent dimer (Non-covalent interactions)
Zhang, Z. PNAS .2002. 97, 7732-7737
SCF-Kit essential for development of: Hematopoietic stem cells
Mast cells Melanocytes Germ cells Interstitial cells of Cajal (ICC’s)
http://images.google.com/imgres?imgurl=http://
Mouse model
Constitutive activation tumorigenic
Kit is encoded by the mouse White locus (W)
Mouse mutants: Null (W -/-):
Pale Died rapidly of anemia
Heterozygotes (W +/-): Haploinsufficient Phenotype varies with gene dosage (e.g. white spotting) Lack network of ICC and ileum aperistaltic
http://www.nature.com/jid/journal/v126/n5/images/5700315i3.jpg
Piebaldism Autosomal dominant disorder Occurs due to mutations disrupting expression of proto-oncogene
protein c-Kit Caused by defective proliferation and migration of melanocytes during
fetal development Characterized by white hair patches on the forehead, anterior trunk and
extremities.
Stolen from Dr. Peifer
Gastrointestinal Stromal Tumors (GISTs) Mesenchymal tumors (connective tissue)
Believed to arise from interstitial cells of Cajal (autonomic nervous
system of the intestine) ICC’s are Kit/STF positive and dependent Subset of multipotential stem cell-like cells
Most frequently GISTs occur in older adults (55-60 yrs)
95% GISTs are caused by
oncogenic mutations of the Kit gene
Kit Mutations in GISTs: Familial:
Autosomal dominant transmission
of constitutional, heterozygous, activating
Sporadic: Exon 11 Exon 9 Exon 13 Exon 17
Mol, C.D et al. Journal of Biological Chemistry. 2003, 278 (34). 31461-31464
GIST therapy: Gleevec
Mol, C.D et al. Journal of Biological Chemistry. 2004, 279 (30). 31655-31663
Gleevec targets active site of kinase.
Gleevec more effective on GISTs caused by mutations in regulatory portion or protein than in the enzymatic region.
References Mol, C.D et al. Journal of Biological Chemistry. 2003, 278 (34). 31461-31464 Reid, R.; de Silva, M.V.C. Pathology Oncology Research. 2003, 9 (1). 13-19. Lasota, J. Miettinen, M. Arch. Pathol. Lab. Med. 2006, 130. 1466-1478. Blume-Jensen, P. et al The EMBO Journal. 1991, 10 (13). 4121-4128. Heinrich, M.C et al Human Pathology. 2002, 33 (5). 484-495. Zhang, Z. PNAS .2002. 97, 7732-7737 Mol, C.D et al. Journal of Biological Chemistry. 2004, 279 (30). 31655-31663